LANZETTA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 16.273
AS - Asia 6.393
EU - Europa 3.983
SA - Sud America 1.501
AF - Africa 129
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.296
Nazione #
US - Stati Uniti d'America 16.065
SG - Singapore 3.020
CN - Cina 1.418
BR - Brasile 1.253
UA - Ucraina 1.070
HK - Hong Kong 745
IT - Italia 698
DE - Germania 600
VN - Vietnam 534
RU - Federazione Russa 395
FI - Finlandia 348
IE - Irlanda 241
TR - Turchia 184
GB - Regno Unito 153
SE - Svezia 153
CA - Canada 118
AR - Argentina 101
KR - Corea 101
IN - India 87
FR - Francia 63
AT - Austria 62
BD - Bangladesh 58
MX - Messico 56
NL - Olanda 56
ID - Indonesia 50
EC - Ecuador 48
ZA - Sudafrica 43
PK - Pakistan 32
PL - Polonia 32
JP - Giappone 28
IQ - Iraq 23
BE - Belgio 22
CO - Colombia 22
PY - Paraguay 21
CL - Cile 20
ES - Italia 19
EG - Egitto 17
UZ - Uzbekistan 15
VE - Venezuela 12
IR - Iran 11
KE - Kenya 11
MA - Marocco 11
TG - Togo 10
AE - Emirati Arabi Uniti 9
PE - Perù 8
RO - Romania 8
TN - Tunisia 8
BO - Bolivia 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
EU - Europa 7
OM - Oman 7
SA - Arabia Saudita 7
UY - Uruguay 7
AU - Australia 6
AZ - Azerbaigian 6
LT - Lituania 6
NP - Nepal 6
DZ - Algeria 5
HU - Ungheria 5
JO - Giordania 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
SN - Senegal 5
BY - Bielorussia 4
CR - Costa Rica 4
JM - Giamaica 4
KG - Kirghizistan 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TW - Taiwan 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IL - Israele 3
KH - Cambogia 3
LB - Libano 3
PR - Porto Rico 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
EE - Estonia 2
IM - Isola di Man 2
IS - Islanda 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
MZ - Mozambico 2
NI - Nicaragua 2
RS - Serbia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
Totale 28.258
Città #
Woodbridge 2.210
Fairfield 1.846
Ann Arbor 1.347
Houston 1.333
Ashburn 1.318
Singapore 1.091
Chandler 948
Beijing 780
Seattle 773
Hong Kong 735
Wilmington 720
Jacksonville 695
Cambridge 623
Dearborn 435
Boardman 349
Princeton 255
Dublin 239
Ho Chi Minh City 166
Los Angeles 165
Udine 163
Izmir 162
New York 134
Dallas 126
San Diego 119
Buffalo 114
Hefei 101
Seoul 98
Hanoi 97
São Paulo 93
Redondo Beach 91
Dong Ket 84
Milan 68
Ogden 68
Munich 67
Des Moines 62
Norwalk 60
Ottawa 51
Grafing 44
Frankfurt am Main 39
Rio de Janeiro 39
Santa Clara 38
Falls Church 34
Belo Horizonte 33
Nuremberg 32
Warsaw 31
Nanjing 29
Porto Alegre 27
Vienna 26
Curitiba 24
Chicago 23
Johannesburg 23
Kunming 23
Phoenix 23
Amsterdam 22
Brasília 22
Brussels 22
Toronto 22
Düsseldorf 21
Montreal 21
Rome 21
Denver 20
London 20
Atlanta 19
Guangzhou 19
Lappeenranta 19
Helsinki 18
Stockholm 18
Wuhan 18
Belluno 17
Boston 17
Campinas 17
Jinan 16
Mexico City 16
Mumbai 16
Orem 16
Brooklyn 15
Guayaquil 15
Haiphong 15
Manchester 15
Quito 15
Tokyo 15
Xi'an 15
Salvador 14
Shenzhen 14
Tashkent 14
Turin 14
Nanchang 13
Thái Bình 13
Chengdu 12
Da Nang 12
Dhaka 12
Naples 12
Redmond 12
Shanghai 12
Trieste 12
Turku 12
Ankara 11
Asunción 11
Bologna 11
Chennai 11
Totale 19.018
Nome #
A mini-invasive surgical technique for Carlevale IOL implantation: case series study and description of concomitant surgery 215
A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer 184
Retinal arteriolar obstruction with progestogen treatment of threatened abortion 181
Aflibercept in the treatment of diabetic macular edema: A review and consensus paper 172
Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction 172
A case of CRB1-negative Coats-like retinitis pigmentosa 171
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 168
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 167
A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema. 165
An unusual and spontaneous resolution of a total rhegmatogenous retinal detachment 164
Advances in pharmacotherapy for wet age-related macular degeneration 162
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion 161
Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane 159
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study 158
Proliferative Diabetic Retinopathy: Treatment Update 158
Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review 157
Neovascular age-related macular degeneration 156
Recommendations for the appropriate management of diabetic macular edema: Light on DME survey and consensus document by an expert panel 155
Ultrastructural Analysis of Rabbit Retina Irradiated with a New 670-nm Diode Red Laser at Different Powers 152
Major ocular complications after organ transplantation 152
Online optical coherence tomography during subthreshold laser irradiation 151
Fluocinolone acetonide for the treatment of diabetic macular edema 151
Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham. 150
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 150
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 150
Retinal neovascularization in a case of macular branch retinal vein occlusion 148
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 148
Ophthalmia Secondary to Cobra Venom Spitting in the Volta Region, Ghana: A Case Report 148
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 148
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 147
Initial clinical experience using a diode red laser (670 nm) in the treatment of retinal disease 146
Global Burden of Visual Impairment and Blindness 146
Dexamethasone implant in diabetic macular edema in real-life situations 144
Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion 143
Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE 143
Optical coherence tomography angiography findings in diabetic retinopathy 143
Advances in the treatment of neovascular age-related macular degeneration 142
A systematic review of endophthalmitis after microincisional versus 20-gauge vitrectomy. 142
Fungal endogenous endophthalmitis secondary to magnusiomyces capitatus 142
Systematic screening of Retinopathy in Diabetes (REaD project): An Italian implementation campaign 141
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis 141
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 141
Author’s response 140
Predictive algorithms for early detection of retinopathy of prematurity 140
A 5-year-old case of choroidal neovascularization in enhanced s-cone syndrome treated with ranibizumab 140
Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia 139
Peribulbar tramadol, clonidine, and ropivacaine in blind and seeing painful eyes 139
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 138
Triple therapy for corneal neovascularization: A case report 138
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 137
Treat-And-Extend Regimens with Anti-Vegf Agents in Retinal Diseases 137
Quality of vision: A consensus building initiative for a new ophthalmologic concept 136
Anatomical and visual outcome of idiopathic macular hole surgery with infracyanine green-assisted peeling ofthe internal limiting membrane 136
Pharmacotherapy for treatment of retinal vein occlusion. 136
Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation 135
Episcleral repair of retinal detachment with the operating microscope and a contact wide-field lens. Pilot study. 135
The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model 135
Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: Post hoc analysis of the VIEW studies 135
Posner-Schlossmann syndrome after accidental ocular exposure to anti-mildew paint 135
Fundus autofluorescence applications in retinal imaging 134
Bilateral juxtafoveolar telangiectasis in monozygotic twins 134
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 133
Efficacy of collagen shields after extracapsular cataract extraction 133
Major ocular complications after organ transplantation 132
Non-proliferative diabetic retinopathy 132
Fluorescein and indocyanine green angiography after transpupillary thermotherapy of choroidal neovascularization. Early vascular changes 131
Living with Geographic Atrophy: An Ethnographic Study 131
Pars plana vitrectomy for refractory diabetic macular edema 130
Selective laser trabeculoplasty 130
Intravitreal injections: a healthcare failure modes and effects analysis. 130
Triamcinolone acetonide for the treatment of diabetic macular oedema 130
Retinal pigment epithelium tear following toxemia of pregnancy 129
Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration 128
Update on combination therapy in wet age-related macular degeneration 128
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 128
Optical coherence tomography of subfoveal choroidal neovascularization treated with transpupillary thermotherapy 127
Diode laser photocoagulation of choroidal hemangioma 126
Ocular complications after hand transplantation 126
Spontaneous resolution of a shallow detachment of the macula in a highly myopic eye 126
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study 126
Surgical treatments of central retinal vein occlusion 125
Posterior lamellar reconstruction: a comprehensive review of the literature 125
ICGA-guided laser photocoagulation of feeder vessels of choroidal neovascular membranes in age-related macular degeneration 124
Scleral fixated intraocular lenses - An angiographic study 123
Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy 123
Diabetic macular edema 123
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 123
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 123
CONTINUOUS-WAVE ND-YAG LASER PHOTOCOAGULATION IN PROLIFERATIVE DIABETIC-RETINOPATHY 123
Retinal pigment epithelium lesions associated with choroidal ischemia in preeclampsia 122
Management of retinal vein occlusion--consensus document 121
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2 121
Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR 121
DIODE AND KRYPTON LASER PHOTOCOAGULATION OF CHOROIDAL NEOVASCULARIZATION (CNV) 120
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 120
Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration Twelve-month MONT BLANC Study Results 120
Topical antibiotics and intravitreal injections 120
Thermotherapy of occult subfoveal choroidal neovascularization 119
Medico-legal implications of traumatic cataract 119
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 119
Totale 14.023
Categoria #
all - tutte 113.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.810 0 0 0 0 0 341 126 295 431 125 280 212
2021/20221.781 83 173 54 85 52 98 145 98 36 315 322 320
2022/20232.205 300 117 21 314 230 608 2 167 299 22 76 49
2023/2024783 121 78 27 17 93 126 28 67 112 36 12 66
2024/20254.898 97 321 195 169 88 210 282 355 560 456 777 1.388
2025/20265.654 830 1.077 1.052 1.202 1.383 110 0 0 0 0 0 0
Totale 28.902